Target Controlled Infusion Pump kanaTCI pombimudziyo wepamusoro wekurapa unonyanya kushandiswa muanesthesiology, kunyanya kudzora kuisirwa kwemishonga yekutindivadza panguva yekuvhiya. Nheyo yekushanda kwayo inobva padzidziso ye pharmacokinetics pharmacodynamics, iyo inofananidzira maitiro nemigumisiro yezvinodhaka mumuviri kuburikidza nekombiyuta simulation, inowana chirongwa chemishonga yakakwana, uye inonyatso kudzora kupinza kwemishonga kuti iwane inotarisirwa plasma concentration kana effect site concentration, nokudaro kuwana kudzora kwakanyatsodzika kwekudzika kweanesthesia. Iyi nzira yekudzora haingochengetedzi yakagadzikana hemodynamics panguva yeanesthesia induction, asi inobvumirawo kugadzirisa nyore kwekudzika kweanesthesia panguva yekuvhiyiwa, kuve nechokwadi chekuchengetedzwa kwemurwere uye kunyaradza. Mukuwedzera, kushandiswa kwechinangwa chinodzorwa pombi kunogonawo kufanotaura kupora uye kupora nguva yevarwere mushure mekuvhiyiwa, kupa nzira iri nyore uye inogadziriswa anesthesia management.
Iwo makuru maficha epombi yekudzora inotarisirwa anosanganisira:
- Kudzora chaiko: Nekutevedzera maitiro uye mhedzisiro yezvinodhaka mumuviri kuburikidza nemakomputa, chirongwa chemishonga chakanakisa chinogona kuwanikwa.
- Smooth transition: Chengetedza hemodynamics yakagadzikana panguva yeanesthesia induction, zvichiita kuti zvive nyore kugadzirisa kudzika kweanesthesia panguva yekuvhiyiwa.
- Kufanotaura nguva yekudzorera: Kukwanisa kufanotaura kupora kwemurwere uye nguva yekudzorera mushure mekuvhiyiwa.
- Kushanda kuri nyore: Nyore kushandisa, yakanaka controllability, yakakodzera kune zvakasiyana siyana zvekuvhiya zvinodiwa.
- Kushandiswa kwemapombi anotungamirirwa nechinangwa hakungogadziri kuchengetedzwa uye kubudirira kwekuvhiyiwa, asiwo kunowedzera kunyaradza kwevarwere uye kugutsikana. Nekufambira mberi kwetekinoroji, mapombi anodzorwa anotariswa anogona kuita basa rakakura mune ramangwana maitiro ekurapa, kunyanya mukuvhiya kwakaoma uye maitiro ekurapa anoda kunyatso kudzora.
Nguva yekutumira: Sep-04-2024
